Role of the standard deviation in the estimation of benchmark doses with continuous data.
For continuous data, risk is defined here as the proportion of animals with values above a large percentile, e.g., the 99th percentile or below the 1st percentile, for the distribution of values among control animals. It is known that reducing the standard deviation of measurements through improved experimental techniques will result in less stringent (higher) doses for the lower confidence limit on the benchmark dose that is estimated to produce a specified risk of animals with abnormal levels for a biological effect. Thus, a somewhat larger (less stringent) lower confidence limit is obtained that may be used as a point of departure for low-dose risk assessment. It is shown in this article that it is important for the benchmark dose to be based primarily on the standard deviation among animals, s(a), apart from the standard deviation of measurement errors, s(m), within animals. If the benchmark dose is incorrectly based on the overall standard deviation among average values for animals, which includes measurement error variation, the benchmark dose will be overestimated and the risk will be underestimated. The bias increases as s(m) increases relative to s(a). The bias is relatively small if s(m) is less than one-third of s(a), a condition achieved in most experimental designs.
Gaylor
David W
DW
Gaylor and Associates, LLC, Little Rock, AR, USA.
Slikker
William
W
D000818:Animals; D016001:Confidence Intervals; D003627:Data Interpretation, Statistical; D004305:Dose-Response Relationship, Drug; D005069:Evaluation Studies as Topic; D015233:Models, Statistical; D019055:No-Observed-Adverse-Effect Level; D011336:Probability; D012107:Research Design; D012306:Risk; D018570:Risk Assessment / Q000379:methods*; D018401:Sample Size; D013223:Statistics as Topic / Q000379:methods*